Spatiotemporal immune zonation of the human kidney.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
27 09 2019
Historique:
received: 05 03 2018
revised: 31 01 2019
accepted: 04 09 2019
entrez: 12 10 2019
pubmed: 12 10 2019
medline: 31 3 2020
Statut: ppublish

Résumé

Tissue-resident immune cells are important for organ homeostasis and defense. The epithelium may contribute to these functions directly or by cross-talk with immune cells. We used single-cell RNA sequencing to resolve the spatiotemporal immune topology of the human kidney. We reveal anatomically defined expression patterns of immune genes within the epithelial compartment, with antimicrobial peptide transcripts evident in pelvic epithelium in the mature, but not fetal, kidney. A network of tissue-resident myeloid and lymphoid immune cells was evident in both fetal and mature kidney, with postnatal acquisition of transcriptional programs that promote infection-defense capabilities. Epithelial-immune cross-talk orchestrated localization of antibacterial macrophages and neutrophils to the regions of the kidney most susceptible to infection. Overall, our study provides a global overview of how the immune landscape of the human kidney is zonated to counter the dominant immunological challenge.

Identifiants

pubmed: 31604275
pii: 365/6460/1461
doi: 10.1126/science.aat5031
pmc: PMC7343525
mid: EMS86701
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1461-1466

Subventions

Organisme : Cancer Research UK
ID : 27176
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N024907/1
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S035842/1
Pays : United Kingdom
Organisme : Department of Health
ID : RP-2017-08-ST2-002
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Références

J Am Soc Nephrol. 2015 Jan;26(1):11-9
pubmed: 24948743
Pediatr Nephrol. 2017 Jun;32(6):1077-1080
pubmed: 28210838
Cell Microbiol. 2014 Oct;16(10):1503-17
pubmed: 24779433
Dev Cell. 2008 Nov;15(5):781-91
pubmed: 19000842
Nat Commun. 2016 Jun 03;7:11703
pubmed: 27256716
Semin Cell Dev Biol. 2014 Dec;36:39-49
pubmed: 25153928
Cell Rep. 2018 Sep 25;24(13):3554-3567.e3
pubmed: 30257215
Science. 2018 Aug 10;361(6402):594-599
pubmed: 30093597
Immunology. 2013 Sep;140(1):22-30
pubmed: 23621371
Nat Protoc. 2009;4(8):1230-43
pubmed: 19644462
N Engl J Med. 1972 Nov 2;287(18):913-9
pubmed: 4561670
Mol Biol Cell. 2004 Feb;15(2):649-56
pubmed: 14657249
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13710-5
pubmed: 14595018
Science. 2017 Jun 9;356(6342):
pubmed: 28473638
Nat Immunol. 2014 Oct;15(10):929-937
pubmed: 25151491
Nature. 2018 Nov;563(7731):347-353
pubmed: 30429548
Nat Immunol. 2016 Apr;17(4):451-60
pubmed: 26878113
Semin Cell Dev Biol. 2014 Dec;36:31-8
pubmed: 25194660
Semin Fetal Neonatal Med. 2008 Jun;13(3):125-32
pubmed: 18096451
Proc Natl Acad Sci U S A. 2002 Jun 11;99(12):8090-5
pubmed: 12060755
J Exp Med. 2017 Sep 4;214(9):2491-2506
pubmed: 28811324
Science. 2016 Apr 22;352(6284):459-63
pubmed: 27102484
FEBS Lett. 2016 Nov;590(22):3987-4001
pubmed: 27597316
Nat Rev Immunol. 2008 Jan;8(1):34-47
pubmed: 18064051
Science. 2012 Apr 6;336(6077):86-90
pubmed: 22442384
Nat Rev Immunol. 2014 Aug;14(8):571-8
pubmed: 25033907
Cell Rep. 2017 Aug 8;20(6):1476-1489
pubmed: 28793269
Science. 2017 Apr 21;356(6335):
pubmed: 28428369
Science. 2016 Sep 9;353(6304):
pubmed: 27492475
Immunity. 2018 Nov 20;49(5):971-986.e5
pubmed: 30413361
PLoS One. 2014 Dec 31;9(12):e116125
pubmed: 25551756
PLoS One. 2012;7(3):e32933
pubmed: 22427910
J Exp Med. 2016 Dec 12;213(13):2861-2870
pubmed: 27864467
Kidney Int. 2019 Apr;95(4):787-796
pubmed: 30826016
Genome Biol. 2019 Mar 22;20(1):63
pubmed: 30902100
Nature. 2001 Apr 26;410(6832):1099-103
pubmed: 11323673
Gigascience. 2020 Dec 26;9(12):
pubmed: 33367645
Development. 2013 Feb;140(4):873-85
pubmed: 23362348
Cell. 2017 Aug 24;170(5):860-874.e19
pubmed: 28803730
Science. 2010 Nov 5;330(6005):841-5
pubmed: 20966214
Science. 2018 May 18;360(6390):758-763
pubmed: 29622724
Nat Biotechnol. 2018 Jun;36(5):411-420
pubmed: 29608179
J Invest Dermatol. 2018 Apr;138(4):811-825
pubmed: 29391249
Nat Biotechnol. 2018 Dec 03;:
pubmed: 30531897
Curr Opin Infect Dis. 2015 Feb;28(1):88-96
pubmed: 25539411
Hum Mol Genet. 2011 Mar 15;20(6):1143-53
pubmed: 21212101
Blood. 1994 Dec 15;84(12):4333-43
pubmed: 7994049
Dev Cell. 2010 May 18;18(5):698-712
pubmed: 20493806
Nat Biotechnol. 2018 Jun;36(5):421-427
pubmed: 29608177
Curr Opin Genet Dev. 2009 Oct;19(5):484-90
pubmed: 19828308
Nat Protoc. 2014 Jan;9(1):209-22
pubmed: 24385150
BMC Genomics. 2006 May 16;7:115
pubmed: 16704732
Bioinformatics. 2017 Apr 15;33(8):1179-1186
pubmed: 28088763
Development. 2018 Aug 30;145(16):
pubmed: 30166318
Development. 2011 Jul;138(13):2845-53
pubmed: 21652655
Circ Res. 2007 Feb 2;100(2):174-90
pubmed: 17272819
Blood. 2011 Aug 4;118(5):e16-31
pubmed: 21653326
Trends Immunol. 2017 Feb;38(2):94-103
pubmed: 27939451
Immunity. 2014 Sep 18;41(3):465-477
pubmed: 25200712
Mol Cell. 2002 Nov;10(5):1045-56
pubmed: 12453413
Immunity. 2006 Jan;24(1):19-28
pubmed: 16413920
J Interferon Cytokine Res. 1996 May;16(5):381-7
pubmed: 8727078
Nat Rev Immunol. 2013 Oct;13(10):738-53
pubmed: 24037418
PLoS One. 2009 Aug 21;4(8):e6709
pubmed: 19696931
Nat Commun. 2017 Jan 16;8:14049
pubmed: 28091601

Auteurs

Benjamin J Stewart (BJ)

Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK.
Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.

John R Ferdinand (JR)

Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.

Matthew D Young (MD)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.

Thomas J Mitchell (TJ)

Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK.
Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.
Department of Surgery, University of Cambridge, Cambridge CB2 0QQ, UK.

Kevin W Loudon (KW)

Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK.

Alexandra M Riding (AM)

Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK.

Nathan Richoz (N)

Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.

Gordon L Frazer (GL)

Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.

Joy U L Staniforth (JUL)

Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.

Felipe A Vieira Braga (FA)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.

Rachel A Botting (RA)

Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Dorin-Mirel Popescu (DM)

Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Roser Vento-Tormo (R)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.

Emily Stephenson (E)

Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Alex Cagan (A)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.

Sarah J Farndon (SJ)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.
Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
UCL Great Ormond Street Hospital Institute of Child Health, London WC1N 1E, UK.

Krzysztof Polanski (K)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.

Mirjana Efremova (M)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.

Kile Green (K)

Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Martin Del Castillo Velasco-Herrera (M)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.

Charlotte Guzzo (C)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.

Grace Collord (G)

Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK.
Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.
Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.

Lira Mamanova (L)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.

Tevita Aho (T)

Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK.

James N Armitage (JN)

Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK.

Antony C P Riddick (ACP)

Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK.

Imran Mushtaq (I)

Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.

Stephen Farrell (S)

Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK.

Dyanne Rampling (D)

Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.

James Nicholson (J)

Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK.
Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.

Andrew Filby (A)

Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.

Johanna Burge (J)

Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK.

Steven Lisgo (S)

Human Developmental Biology Resource, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne NE1 3BZ, UK.

Susan Lindsay (S)

Human Developmental Biology Resource, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne NE1 3BZ, UK.

Marc Bajenoff (M)

Centre d'Immunologie de Marseille-Luminy, 13009 Marseille, France.

Anne Y Warren (AY)

Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK.

Grant D Stewart (GD)

Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK.
Department of Surgery, University of Cambridge, Cambridge CB2 0QQ, UK.

Neil Sebire (N)

Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK.
UCL Great Ormond Street Hospital Institute of Child Health, London WC1N 1E, UK.

Nicholas Coleman (N)

Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK.
Department of Pathology, University of Cambridge, Cambridge CB2 1QP, UK.

Muzlifah Haniffa (M)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.
Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Department of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne NE2 4LP, UK.

Sarah A Teichmann (SA)

Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK. mrc38@cam.ac.uk sb31@sanger.ac.uk st9@sanger.ac.uk m.a.haniffa@newcastle.ac.uk.
Theory of Condensed Matter Group, Cavendish Laboratory-Department of Physics, University of Cambridge, Cambridge CB3 0HE, UK.

Sam Behjati (S)

Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK.
Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.
Department of Paediatrics, University of Cambridge, Cambridge CB2 0QQ, UK.

Menna R Clatworthy (MR)

Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
Cambridge University Hospitals NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 0QQ, UK.
Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton CB10 1SA, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH